Date | Title | Description | Source |
29.03.2023 | Startup Showcase: Alzinova AB – Pioneering Alzheimer’s Disea... | Alzinova AB is a Swedish biotechnology company engaged in drug discovery research for Alzheimer’s di... | eustartup.... |
01.11.2022 | Alzinova AB interim report January – September 2022 | Alzinova AB interim report January – September 2022
Tue, Nov 01, 2022 08:01 CET Report this content
... | news.cisio... |
07.09.2022 | Alzinova announces new positive safety review of its Phase 1... | Alzinova announces new positive safety review of its Phase 1b study in Alzheimer’s disease
Wed, Sep ... | news.cisio... |
25.08.2022 | Alzinova AB interim report January – June 2022 | Alzinova AB interim report January – June 2022
Thu, Aug 25, 2022 08:01 CET Report this content
The B... | news.cisio... |
03.08.2022 | Alzinova has recruited half of the patients for the ongoing ... | Alzinova has recruited half of the patients for the ongoing Phase 1b study of the vaccine candidate ... | news.cisio... |
05.07.2022 | Alzinova establishes scaled-up manufacturing process for ALZ... | Alzinova establishes scaled-up manufacturing process for ALZ-101 ahead of Phase 2
Tue, Jul 05, 2022 ... | news.cisio... |
01.07.2022 | Conversion of BTU into shares and warrants of series TO3 | Conversion of BTU into shares and warrants of series TO3
Fri, Jul 01, 2022 12:33 CET Report this con... | news.cisio... |
15.06.2022 | Alzinova announces outcome of rights issue | Alzinova announces outcome of rights issue
Wed, Jun 15, 2022 08:01 CET Report this content
Alzinova ... | news.cisio... |
08.06.2022 | Alzinova appoints Mangold Fondkommission as new liquidity pr... | Alzinova appoints Mangold Fondkommission as new liquidity provider
Wed, Jun 08, 2022 08:01 CET Repor... | news.cisio... |
30.05.2022 | The subscription period in Alzinova’s rights issue starts to... | The subscription period in Alzinova’s rights issue starts today
Mon, May 30, 2022 08:01 CET Report t... | news.cisio... |
24.05.2022 | Alzinova publishes prospectus in connection with rights issu... | Alzinova publishes prospectus in connection with rights issue of units
Tue, May 24, 2022 10:11 CET R... | news.cisio... |
24.05.2022 | Alzinova initiates development of a stable cell line to prep... | Alzinova initiates development of a stable cell line to prepare the monoclonal antibody ALZ-201 for ... | news.cisio... |
18.05.2022 | Bulletin from the annual general meeting of Alzinova AB (pub... | Bulletin from the annual general meeting of Alzinova AB (publ)
Wed, May 18, 2022 15:48 CET Report th... | news.cisio... |
28.04.2022 | Alzinova announces positive safety review and continuation o... | Alzinova announces positive safety review and continuation of its Phase 1b study in Alzheimer’s dise... | news.cisio... |
19.04.2022 | Alzinova AB interim report January – March 2022 | Alzinova AB interim report January – March 2022
Tue, Apr 19, 2022 07:46 CET Report this content
The ... | news.cisio... |
19.04.2022 | The Board of Directors resolves on a rights issue of units o... | The Board of Directors resolves on a rights issue of units of approximately SEK 42.5 million, part o... | news.cisio... |
19.04.2022 | Notice of annual general meeting in Alzinova AB (publ) | Notice of annual general meeting in Alzinova AB (publ)
Tue, Apr 19, 2022 08:36 CET Report this conte... | news.cisio... |
14.04.2022 | Alzinova publishes the Annual Report for 2021 | Alzinova publishes the Annual Report for 2021
Thu, Apr 14, 2022 07:46 CET Report this content
Alzino... | news.cisio... |
30.03.2022 | Alzinova improves manufacturing process of ALZ-101 to meet p... | Alzinova improves manufacturing process of ALZ-101 to meet phase 2 requirements
Wed, Mar 30, 2022 08... | news.cisio... |
24.02.2022 | Alzinova AB Year end report 2021 | Alzinova AB Year end report 2021
Thu, Feb 24, 2022 08:01 CET Report this content
The Board of Direct... | news.cisio... |
10.02.2022 | Alzinova receives approximately SEK 2,8 million through the ... | Alzinova receives approximately SEK 2,8 million through the exercise of the warrants of series TO2 2... | news.cisio... |
03.02.2022 | Today is the last day of trading in Alzinova's warrants of s... | Today is the last day of trading in Alzinova's warrants of series TO2 2020/2022
Thu, Feb 03, 2022 08... | news.cisio... |
26.01.2022 | Alzinova announces that Mangold Insight initiates equity res... | Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments of Alzheimer's d... | marketscre... |
26.01.2022 | Alzinova announces that Mangold Insight initiates equity res... | Alzinova announces that Mangold Insight initiates equity research coverage of the company Wed, Jan 2... | news.cisio... |
24.01.2022 | The exercise period for Alzinova's warrants of series TO2 20... | The exercise period for Alzinova's warrants of series TO2 2020/2022 begins today Mon, Jan 24, 2022 0... | news.cisio... |
20.01.2022 | Alzinova completes humanisation work and selects lead candid... | Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company, today announces the company has succe... | marketscre... |
20.01.2022 | Alzinova completes humanisation work and selects lead candid... | Alzinova completes humanisation work and selects lead candidate for monoclonal antibody ALZ-201 Thu,... | news.cisio... |
15.12.2021 | Preclinical data confirm the unique specificity and disease-... | Preclinical data confirm the unique specificity and disease-modifying potential of Alzinova’s monocl... | news.cisio... |
15.12.2021 | Preclinical data confirm the unique specificity and disease-... | Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments of Alzheimer's d... | marketscre... |
29.10.2021 | First patient recruited into Alzinova's phase 1b clinical st... | Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company developing treatments of Alzheimer's d... | marketscre... |
29.10.2021 | First patient recruited into Alzinova's phase 1b clinical st... | STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma compa... | marketscre... |
29.10.2021 | First patient recruited into Alzinova’s phase 1b clinical st... | First patient recruited into Alzinova’s phase 1b clinical study with the oligomer-specific ALZ-101 v... | news.cisio... |
28.10.2021 | Alzinova AB interim report January – September 2021 | Alzinova AB interim report January – September 2021 Thu, Oct 28, 2021 08:01 CET
The Board of Directo... | news.cisio... |
30.09.2021 | Alzinova receives approval to start the first clinical study... | Alzinova receives approval to start the first clinical study with the oligomer-specific ALZ-101 vacc... | news.cisio... |
30.09.2021 | Alzinova : receives approval to start the first clinical stu... | STOCKHOLM, Sept. 30, 2021 /PRNewswire/ -- Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma comp... | marketscre... |
30.09.2021 | Alzinova : receives approval to start the first clinical stu... | Alzinova AB (publ) (FN STO: ALZ), a Swedish biopharma company specialising in the treatment of Alzhe... | marketscre... |
26.08.2021 | Alzinova AB : interim report January - June 2021 | The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim rep... | marketscre... |
26.08.2021 | Alzinova AB interim report January – June 2021 | Alzinova AB interim report January – June 2021 Thu, Aug 26, 2021 08:01 CET
The Board of Directors an... | news.cisio... |
26.07.2021 | Alzinova presents preclinical data on Alzheimer disease cand... | Alzinova presents preclinical data on Alzheimer disease candidates at the AAIC conference Mon, Jul 2... | news.cisio... |
19.05.2021 | Alzinova AB interim report January – March 2021 | Alzinova AB interim report January – March 2021 Wed, May 19, 2021 08:01 CET
The Board of Directors a... | news.cisio... |
18.05.2021 | ALZINOVA AB
Alzinova : Bulletin from the annual general mee... | The following resolutions were passed at the annual general meeting (the "AGM") of Alzinov... | marketscre... |
18.05.2021 | Bulletin from the annual general meeting of Alzinova AB (pub... | Bulletin from the annual general meeting of Alzinova AB (publ) Tue, May 18, 2021 14:19 CET
The follo... | news.cisio... |
21.04.2021 | ALZINOVA AB
Alzinova : Status update regarding application ... | Alzinova announces today that the documentation required for the application to start the planned Ph... | marketscre... |
29.10.2020 | Alzinova : AB interim report January - September 2020 | STOCKHOLM, Oct. 29, 2020 /PRNewswire/ -- The Board of Directors and the Chief Executive Officer of A... | marketscre... |